Robinhood CEO rejects issuer veto over AMC-linked stock tokens
Vlad Tenev says consent is only needed if a token changes shareholder rights or the official shareholder record.
Robinhood CEO Vlad Tenev escalated a public dispute with AMC Entertainment CEO Adam Aron by arguing issuers should not be able to block third-party stock tokens that reference their shares. Aron has demanded Robinhood halt AMC-linked tokens and has threatened to take the issue to the U.S. Securities and Exchange Commission.
Key Takeaways
- Robinhood CEO Vlad Tenev argued public companies should not be able to block blockchain-based products tied to their shares if shareholder rights and the authoritative shareholder record are unchanged.
- AMC CEO Adam Aron demanded Robinhood stop offering tokens linked to AMC shares and said he may raise the issue with the U.S. Securities and Exchange Commission.
- Robinhood launched stock tokens outside the U.S. in 2026, offering exposure to hundreds of U.S. stocks and ETFs.
- Tenev described the tokens as separate instruments backed 1:1 by underlying shares that provide economic exposure without placing holders on a company’s shareholder register.
Tenev’s ‘No Issuer Veto’ Line in the AMC Token Fight
Robinhood CEO Vlad Tenev drew a bright line on issuer consent for tokenized equities in an X post late Friday, framing the fight as a question of investor rights and recordkeeping rather than the use of blockchain rails.
“A company should control the rights attached to its shares — not every lawful use of those shares once they're in investors' hands,” Tenev wrote. “Going onchain shouldn't give the issuer a veto it never had offchain.”
The post directly rebuts AMC Entertainment CEO Adam Aron, who demanded on Sept. 4 that Robinhood stop offering tokens linked to AMC shares and threatened to take the dispute to the U.S. Securities and Exchange Commission. Aron’s core claim is that the product creates a parallel market in AMC exposure without AMC’s consent, and that the confusion around what token holders actually own is itself an investor-protection problem.
Aron labeled Robinhood’s product a “fictitious synthetic equity market” and argued it could weaken AMC’s ability to raise capital, confuse investors about their rights, and create a market bearing AMC’s name without AMC’s approval.
How Robinhood Says Its Stock Tokens Work: 1:1 Backing, No Shareholder Register
Robinhood launched its stock tokens outside the U.S. in 2026, offering exposure to hundreds of American stocks and exchange-traded funds. The cross-border placement matters because it sets the compliance perimeter and, in practice, determines which disclosure regime and enforcement posture will do the real work.
Tenev’s description of the structure is explicit: the tokens are “separate financial instruments” backed 1:1 by underlying shares. The promise is economic exposure that tracks the referenced stock, while keeping token holders off the issuer’s shareholder register.
That “no shareholder register” point is the fulcrum. If token holders are not on the authoritative record, they are not shareholders in the legal sense, and they should not expect shareholder rights by default. Tenev’s framing is that the issuer’s rights and obligations remain intact because the product does not rewrite the company’s official ledger or alter the rights attached to the underlying shares.
The catch is that the packet does not include Robinhood’s detailed product terms, custody mechanics for the 1:1 backing, or the exact jurisdictions and venues where the tokens trade. Traders can only work with what is stated: 1:1 backing is claimed, and token holders are not placed on the shareholder register.
Issuer Consent as the Fault Line: Options, Unsponsored ADRs, and the Onchain Analogy
Tenev’s issuer-consent test is designed to make tokenized equities look like familiar wrappers rather than “shares onchain.” He wrote: “If it creates a separate financial instrument that holds or references freely transferable shares without changing the issuer’s rights, obligations, or authoritative shareholder record, issuer consent should not be required.”
He anchored that argument in existing market structure. Options, unsponsored American depositary receipts, and structured products can reference public shares without giving the underlying company control over the instrument. The implication is straightforward: if legacy markets tolerate issuer-independent exposure products, moving the wrapper onchain should not create a new permission layer for issuers.
Tenev also defined where issuer involvement should be mandatory. “If a product purports to change the rights attached to the underlying shares, replaces the company’s official stock ledger, or imposes new obligations on the company or its transfer agent, the issuer should be involved,” he wrote. That boundary condition is a direct answer to the most sensitive part of tokenized equities: whether a product is merely price exposure, or whether it is trying to become the record of ownership.
AMC’s objections sit on the other side of that line. Aron is arguing that even if the product is technically a separate instrument, it can still create practical harm through investor confusion and capital-markets optics, especially if buyers interpret “AMC token” as something closer to an AMC-issued security than a third-party wrapper.
Regulatory status is the unresolved overhang. Tenev acknowledged the rules may evolve, writing: “Investors should know what they own, what rights it carries, and whether the issuer is involved.” The packet includes no SEC response, no enforcement action, and no indication that the agency has taken up Aron’s threatened escalation.
What I’d Watch Next: SEC Posture, Disclosure Standards, and Copycat Issuer Pushback
Any public SEC response is the first real catalyst, even if it is only informal guidance or an inquiry referenced by either side. The market can trade around a lot of ambiguity, but it cannot trade around a regulator drawing a line on what counts as a security, what disclosures are required, and who is responsible for them.
The second test is disclosure quality, not slogans. If Robinhood or competitors publish tighter terms on custody and the 1:1 backing mechanics, plus a plain-English map of token-holder rights versus shareholder rights, the product starts to look like an issuer-independent wrapper with standardized expectations. If that detail stays thin while more tickers get added, issuer pushback becomes a repeatable headline risk.
The Part of Robinhood- AMC dispute over tokenized stocks That Matters
The threshold that matters is whether tokenized equities get treated as “shares” for issuer-control purposes, or as issuer-independent exposure instruments that live and die on disclosure. Tenev is explicitly trying to force the second framing, using options, unsponsored ADRs, and structured products as the precedent set.
If the model holds up under scrutiny, the practical outcome is simple: tokenized-equity venues can scale listings without negotiating issuer participation. If regulators or issuers succeed in tying these products to issuer consent, the category compresses into a permissioned market where distribution is the bottleneck, not blockchain settlement.
